KaloBios Pharmaceuticals Secures $12,000,000 Series D Financing

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b2c7937c-f279-450c-a43c-e375e50fc788&Preview=1
Date
12/22/2008
Company Name
KaloBios Pharmaceuticals
Mailing Address
260 East Grand Avenue South San Francisco, CA 94080
Company Description
KaloBios is a vertically integrated therapeutic antibody company using its proprietary antibody engineering, humaneering and expression technologies for the development of a pipeline of antibody therapeutics.
Website
http://www.kalobios.com
Transaction Type
Venture Equity
Transaction Amount
$12,000,000
Transaction Round
Series D
Proceeds Purposes
Proceeds purposes were not disclosed.
M&A Terms
Venture Investor
Genzyme Ventures
Venture Investor
MPM Capital
Venture Investor
Alloy Ventures
Venture Investor
GBS Venture Partners
Venture Investor
Sofinnova Ventures
Venture Investor
5AM Ventures
Venture Investor
Undisclosed